Diego Claro de Mello

6PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersReaction engineering (excl. nuclear reactions)Cellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Activation of EZH2 Promoter Is Mediated by MAPK Signaling Regulated Transcription Factors in Anaplastic Thyroid Cancer.

|Feb 12, 2026
Dual Effect of EZH2 Gene Editing with CRISPR/Cas9 in Lung Cancer.

Joice M Menezes, Diego C de Mello, Kelly C Saito

|Oct 28, 2025
Targeting EZH2 reverses thyroid cell dedifferentiation and enhances iodide uptake in anaplastic thyroid cancer.

Diego Claro de Mello, Marcella Maringolo Cristovão, Guilherme Henrique

|Jan 29, 2025
Modulating gene expression as a strategy to investigate thyroid cancer biology.

Diego Claro de Mello, Joice Moraes Menezes, Antonio Tarelo Freitas de Oliveira

|Jun 26, 2024
Epigenetic Regulation of DLK1-DIO3 Region in Thyroid Carcinoma.

Letícia F Alves, Isabelle N da Silva, Diego C de Mello

|May 13, 2023
Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer.

Diego Claro de Mello, Kelly Cristina Saito, Marcella Maringolo Cristovão

Pageof 1

Frequent Collaborators

4 joint publications

Cesar Seigi Fuziwara

4 joint publications

Edna Teruko Kimura

2 joint publications

Kelly Cristina Saito

2 joint publications

Marcella Maringolo Cristovão